Announcements Trials
Browse Landscape

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 164Breast Neoplasms 111Colorectal Neoplasms 77Neoplasms 64Lung Neoplasms 61Pancreatic Neoplasms 56Stomach Neoplasms 52Neoplasm Metastasis 51Ovarian Neoplasms 45Rectal Neoplasms 43Esophageal Squamous Cell Carcinoma 38Esophageal Neoplasms 38Head and Neck Neoplasms 34Squamous Cell Carcinoma of Head and Neck 32Leukemia, Myeloid, Acute 32Triple Negative Breast Neoplasms 25Recurrence 25Small Cell Lung Carcinoma 24Precursor Cell Lymphoblastic Leukemia-Lymphoma 24Colonic Neoplasms 23Nasopharyngeal Carcinoma 22Glioblastoma 22Uterine Cervical Neoplasms 21Lymphoma 21Lymphoma, Non-Hodgkin 20Fallopian Tube Neoplasms 20Prostatic Neoplasms 17Melanoma 17Sarcoma 16Leukemia 16

Interventions

Transcranial Direct Current Stimulation 1Spermine Synthase 1Radiosurgery 1Palliative Care 1Modafinil 1Methods 1Mental Status and Dementia Tests 1Magnetic Resonance Spectroscopy 1Lovastatin 1Lomustine 1Lamotrigine 1Functional Status 1Exercise 1Drug Therapy 1Donepezil 1DNA Methylation 1Cognitive Training 1Bevacizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Cognition Disorders × Drug Therapy × Clear all
NCT02753036 2021-08-19

CICARO

Charite University, Berlin, Germany

Unknown
72 enrolled

Chemotherapy-Related Cognitive Impairment, Cognition Disorders, Neoplasms, Polyneuropathies

Data powered by HemOnc (CC BY 4.0) Colophon âš¡